ArticlePDF Available

Colorimetric method for the determination of paromomycin sulfate in bulk and dosage forms using ascorbic acid

Authors:

Abstract and Figures

A simple and accurate colorimetric method was developed for the estimation of paromomycin sulphate (PM) in bulk and pharmaceutical formulations. The method was based on generation of colored complex from reaction between PM and ascorbic acid having analytically useful maxima at 390 and 530 nm. The factors such as concentration of ascorbic acid and heating time affecting the color development were optimized and incorporated in the procedure. Regression analysis of Beer's plot showed good correlation (r=0.999) in a concentration range of 40-200µg/mL. The limits of detection and quanification at 390 and 530nm were 3.95µg/mL, 5.95µg/mL and 13.17µg/mL, 19.83µg/mL, respectively. The average recovery for the commercial preparation (Paromomycin Sulfate injections, 1g/ 2 mL) was 102.23±3.37%; n=3, which reflected no interference by the injection excipients. Based on the molar ratio method, the reaction stoichiometry was found to be 1:1.
Content may be subject to copyright.
www.scholarsresearchlibrary.comt Available online a
Scholars Research Library
Der Pharmacia Lettre, 2016, 8 (17):26-31
(http://scholarsresearchlibrary.com/archive.html)
ISSN 0975-5071
USA CODEN: DPLEB4
26
Scholar Research Library
Colorimetric method for the determination of Paromomycin Sulfate in Bulk
and Dosage forms using Ascorbic acid
Mohamed E. Adam, Shaza W. Shantier*, Reem S., Magdi A. Mohamed
and Elrasheed A. Gadkariem
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Khartoum, P.O. Box 1996,
Khartoum, Sudan
_____________________________________________________________________________________________
ABSTRACT
A simple and accurate colorimetric method was developed for the estimation of paromomycin sulphate (PM) in bulk and
pharmaceutical formulations. The method was based on generation of colored complex from reaction between PM and ascorbic
acid having analytically useful maxima at 390 and 530 nm. The factors such as concentration of ascorbic acid and heating time
affecting the color development were optimized and incorporated in the procedure. Regression analysis of Beer's plot showed
good correlation (r=0.999) in a concentration range of 40-200µg/mL. The limits of detection and quanification at 390 and
530nm were 3.95µg/mL, 5.95µg/mL and 13.17µg/mL, 19.83µg/mL, respectively. The average recovery for the commercial
preparation (Paromomycin Sulfate injections, 1g/ 2 mL) was 102.23±3.37%; n=3, which reflected no interference by the
injection excipients. Based on the molar ratio method, the reaction stoichiometry was found to be 1:1.
Key words: Paromomycin, Ascorbic acid, Spectrophotometric
_____________________________________________________________________________________________
INTRODUCTION
Paromomycin sulfate (Figure 1), is a broad spectrum antibiotic produced by streptomyces riomosus var. It is used to
treat intestinal infection such as cryptosporidiosis and amebiasis and other disease like lishmaniasis. Paromomycin
topical cream with or without gentamicin is an effective treatment for ulcerative cutaneous leishmaniasis [1].
Many HPLC methods were reported for determination of Paromomycin alone and in combination with other
amnioglycosides (2-4). Ascorbic acid has been frequently utilized as an analytical reagent in pharmaceutical
analysis. It was used for the colorimetric determination of penicilins, cephalosporins having α-aminoacyl functions
and aminoglycosides (5-10). Based on these reports, simple, sensitive and accurate colorimetric method was
developed for the determination of PM in bulk and injection forms using ascorbic acid.
Shaza W. Shantier et al Der Pharmacia Lettre, 2016, 8 (17):26-31
______________________________________________________________________________
27
Scholar Research Library
Figure 1: Chemical structure of Paromomycin sulphate
MATERIALS AND METHODS
Paromomycin sulfate standard was kindly provided by the Central Lab, Sudan. Paromomycin sulfate Injection
(1g/2ml), Gland pharm Ltd, India.
Ascorbic acid, British drug house, England. Dimethylsulfoxide (DMSO) s.d Fine chem. Limited, India. Dimethyl
Formamide (DMF), Merck K.G.A, Germany.
Spectrophotometric studies were carried out on Shimadzu UV-1800ENG240V, Koyoto, Japan.
Preparation of stock solutions
Standard stock solution
0.01g of paromomycin sulfate standard was accurately weighed and dissolved in 10ml distilled water. The solution
was transferred into 25ml volumetric flask and the volume was completed to mark with distilled water (solution A;
4000µg/ml).
Sample stock solution
0.2ml of the sample injection was diluted to 10ml with distilled water. 1ml of the resultant solution was further
diluted to 25ml using distilled water (solution B; 4000µg/ml).
Reagent blank
Two ml of 0.2%w/v ascorbic acid was added to 0.5ml distilled water and the volume was completed to 10ml with
DMSO.
Procedure
Construction of calibration curve
Aliquot volumes from solution A (0.1 ˗ 0.5ml) were transferred into five stoppered glass tubes. 0.4, 0.3, 0.2, 0.1 and
0.0 ml of distilled water were added to each tube, respectively. 2ml of freshly prepared ascorbic acid (0.2% w/v) was
added to each tube. The solutions were completed to10 ml with DMSO before heating in boiling water bath for
45minutes.
The absorbance of the resultant solutions was measured at 390 and 530 nm against the reagent blank. The graphs
were then constructed by plotting the absorbance values versus drug concentration at each wave length.
Serial dilutions of solution B were treated as under calibration curve. The content of injection was alternatively
determined by direct sample/standard comparison.
H
2
SO
4
Shaza W. Shantier et al Der Pharmacia Lettre, 2016, 8 (17):26-31
______________________________________________________________________________
28
Scholar Research Library
Optimization of reaction conditions
Effect of heating time
Reaction mixtures of PM standard solution (160µg/ml) and ascorbic acid were heated at time interval (15minutes).
The absorbance values were then measured to determine the optimum heating time.
Effect of Ascorbic acid concentration
Two ml of freshly prepared ascorbic acid solutions (0.1%, 0.2% and 0.3%w/v) was transferred into three stoppered
glass tubes containing PM standard solution (120µg/ml). The solutions were then treated as under calibration curve.
Validation of the developed method
The developed method was validated in terms of linearity, accuracy (added recovery method) and precision
(repeatability and reproducibility).
Reaction stoichiometry
Serial volumes (0.1 ˗0.7ml) of PM standard solution (1.5x10
-2
M) were transferred into seven stoppered glass tubes.
0.6, 0.5, 0.4, 0.3, 0.2, 0.1 and 0.0 ml of distilled water were then added, respectively. 0.3ml of freshly prepared
ascorbic acid solution (1.5x10
-2
M) was added to each tube. The volumes were completed to 10ml with DMSO,
heated for 45minutes and the absorbance values were then measured at 390nm and 530nm against blank.
The molar ratio of the reaction was obtained from a plot of concentration ration ([PM]/ [ascorbic acid]) vs
absorbance values. RESULTS AND DISCUSSION
Colorimetry is concerned with the determination of the concentration of substances by measurement of the relative
absorption of light with respect to a known concentration of the substance.
The chief advantage of UV/ visible spectrophotometric methods is that it provides a simple means for determining
quantities of substances. Weakly or non UV absorbing compounds can be allowed to react with a reagent to give a
colored compound with higher intensity absorption depending on the presence of an active functional group such as
NH
2
, OH …etc
PM like other aminoglycosides is composed of 2- deoxystreptamine and teterahydropyran ring to which the amino
groups are attached. PM exhibits weak UV/absorption therefore, a suitable chromogen is needed to form an
absorbing chromophore that can be used for simple and sensitive determination of PM in bulk and in different
pharmaceutical formulation.
Figure 2: UV/VIS spectrum of the colored product (40µg/ml)
Ascorbic acid is reported to have a selective reaction with ammonia and primary aliphatic amines (11) and has been
used for colorimetric determination of number of drugs containing primary amine (12, 13).
Shaza W. Shantier et al Der Pharmacia Lettre, 2016, 8 (17):26-31
______________________________________________________________________________
29
Scholar Research Library
Thus, the developed method is based on reaction of PM with ascorbic acid in presence of DMSO to produce a pink-
purple colored complex with λ
max
390 and 530nm (Figure 2)
Optimization of reaction conditions
The different experimental factors affecting the color development, intensity and stability were studied.
Heating was found necessary for oxidation of ascorbic acid and hence the formation of a colored complex. The
maximum colored was developed after heating for 60 minutes; however more consistent results were obtained when
heating in a boiling water bath for 45minutes which was selected as a fixed time of heating (Table 1).
Table1. Effect of heating time on color intensity
λ
max
Heating time (minutes) / Absorbance values (160µg/ml)
15 30 45 60
390nm 0.345 0.900 1.128 1.199
530nm 0.115 0.266 0.367 0.401
For faster and intense color development, DMSO was used as solvent. As reported by Pesez and Bartos (14), the
sample should contain no more than 1%v/v water in the final volume for high sensitivity and color stability.
2ml of 0.2%w/v ascorbic acid was chosen as the optimum concentration for maximum color development and
stability (Figure 3).
.
Figure 3: Effect of ascorbic acid concentration on color intensity
The sequence of reagents addition as described in the method was found essential for color development and
stability (not less than 24 hours).
Method validation
Linearity
The constructed calibration curves obeyed Beer’s law over the concentration range 40 ˗ 200µg/ml with good
correlation coefficient. The linearity data was calculated at 95% confidence limit and summarized in Table 2.
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.00% 0.05% 0.10% 0.15% 0.20% 0.25% 0.30% 0.35%
Absorbance
ascorbic acid concentration (%w/v)
Shaza W. Shantier et al Der Pharmacia Lettre, 2016, 8 (17):26-31
______________________________________________________________________________
30
Scholar Research Library
Table 2. Linearity data of the developed method
Parameter Wavelength
390nm 530nm
Slope ± ts
0.0072±2.40 x10
-
4
0.0025±1.27x10
-
4
Intercept ± ts
a
0.005±0.038 -0.007±0.017
Correlation coefficient
0.9998
0.9996
Range 40 ˗ 200µg/ml 40 ˗ 200µg/ml
LOD 3.95µg/ml 5.95µg/ml
LOQ 13.17µg/ml 19.83µg/ml
Analytical assay
The developed method was successfully applied for the quantitation of PM injection formulation. The injection
content percent was found 103.03 ±1.6 % and 101.95±1.91%; n=4 at 390nm and 530nm, respectively. Alternatively,
the assay results were calculated using the following adopted formula:
Content% =  slopeofsamplecurve
slopeofstandardcurve x100
Scheme 1. Proposed mechanism for the color producing reaction
Accuracy and precision
The recovery percentage method was applied to evaluate the accuracy of the procedure and the freedom from
interference by the injection excipients. The obtained results showed good recovery of the injection (102.10±3.32%
and 102.10 ±3.37%; n=3 at 390nm and 530nm, respectively), which reflected the accuracy of the developed method.
Shaza W. Shantier et al Der Pharmacia Lettre, 2016, 8 (17):26-31
______________________________________________________________________________
31
Scholar Research Library
Three concentrations of PM within the linearity range were used to evaluate the precision of the developed method.
The obtained RSD% values for the within-day and between-days determination were within the range 0.00 ˗ 1.70%
and 0.56 ˗ 1.14%; n=3. These low values (less than 2%) reflected the precision of the developed method.
Proposed reaction mechanism
The reaction between PM and ascorbic acid was found to proceed with a 1:1 ratio as determined by the molar ratio
method. The reaction is proposed to take place via nucleophic addition mechanism with PM and dehydroascorbic
acid being the nucleopile and the electrophile, respectively (Scheme 1). The mechanism involves the reaction of the
PM's less sterically hindered amino group with the carbon of the most electrophilic carbonyl group of
dehydroascorbic acid to generate an imine (tautomer I). The resultant imine undergoes tautomerism to give
tautomers II, III or IV (scheme 1). Tautomer IV appears to be the most stable as it can be envisioned as a derivative
of the aromatic heterocycle furan. The furan derivative, tautomer IV, absorbs UV/visible at two wave lengths, 530
and 390 nm. The low intensity absorption at 530 nm is supposed to be due to n=π
*
transition whereas the high
intensity absorption at 390 nm is supposed to be due to π=π
*
transition. The proposed mechanism explains why one
mole ascorbic acid is required to couple with one mole of PM to yield the color coupling complex.
CONCLUSION
The developed method was proved to be simple, accurate and precise for the determination of PM in bulk and
dosage forms. Ascorbic acid is considered a suitable, cheap and available reagent for the analysis of PM without
interference from excipients. The developed method can be used for the routine analysis of PM.
REFERENCES
[1] S. Sweetman, Martindale: The Complete Drug Reference, London, Pharmaceutical Press, 2002, 33
rd
ed.
[2] J. Pick, L.L. Oison, WY. Ellis, P. Lim, J. Pharm. Biomed. Anal., 1997, 16, 1, 131-137.
[3] R. Oretel, V. Neumeister, W. Kirch, J. chroma. A, 2004, 1058, 1-2, 197-201.
[4] L.L. Oison, J. Pick, WY. Ellis, P. Lim. J. Pharm. Biomed. Anal., 1997, 15, 6, 783- 793
[5] E.A. Gadkariem, M.A Abounassif, A.M. Wahabi, Talanta, 1985, 33, 180-181.
[6] H.A.AL- Khamees, F.S. El- Shafie, M.E. Hagga, M.E. Alawady , E.A. GadKariem, Sci. Pharm., 1995, 63, 191.
[7] N. Rahman, M. Sing, M. Nasrulhoda, J. Braz. Chem. Soci., 2005, 16, 5, 1001-1009.
[8] S.W. Shantier, E. A GadKariem , K.E Ibrahim, Int. J. Dru. Form. Res., 2012, 2, 260-272.
[9] S.W. Shantier, E. A GadKariem, K.E Ibrahim, M.E. Hagga, Res. J. Pharm. Bio. Chem. Sci., 2012, 3, 1, 566-573.
[10] H.A. ELobied, E.A.Gadkariem, K.A. AL.Rashood, H.A. Al-Khamees, F.S. El- Shafie, G.A.M. Bawazeer, Anal.
Lett., 1999, 32,14, 2809-2823.
[11] E.A. Gadkariem, M.M. Mutasim, K.E.Ibrahim, H.A. El-Obeid, J. Biomed. Sci., 2009, 5, 267-274.
[12] F.S. El-Shafie, E.A. Gadkariem, K.A. Al-Rashood, H.A. Al-Khamees, H.A. El-Obeid, Anal Lett., 1996, 29, 3,
381–393.
[13] H.A. El-Obeid, E.A. Gadkariem, K.A. Alrashood, H.A. Al-Khamees, F.S. El-Shafie, G.A.M. Bawazeer, Anal
Lett., 1999, 32, 2809–2823.
[14] M. Pesez, J. Bartos . Aliphatic amine textbook of colorimetric and fluorimetric analysis of organic compounds
and drugs. 1974. p.155.
... The amount of PM incorporated into nanoemulsions was determined by the colorimetric method, according to the methodology proposed by Adam et al. (2016). Where the reaction between PM and ascorbic acid generates a colored complex, which is analyzed at wavelengths 390 and 530 nm. ...
... The system was then heated to 45 • C for 30 min. The absorbance of the NE samples was determined using a calibration curve (Adam et al., 2016). Absorbances were measured at 390 nm and 530 nm against the reagent blank. ...
... Ascorbic acid, an inexpensive naturally occurring compound, was explored as a coupling reagent to improve the UV-VIS profile of amikacin. Reaction of amikacin with ascorbic acid in DMSO led to the formation of a pink-purple colored complex [8] with absorbance peaks at 390 nm and 540 nm, facilitating spectrophotometric quantification. ...
... Ascorbic acid concentrations were optimized by reacting amikacin (0.5 ml) with solutions of different concentrations (0.1-0.3% w/v) in the selected solvent. The concentration producing the most intense pink color and highest stability at 540 nm was chosen for formulating the coupling reagent solutions [8]. ...
Article
Full-text available
A sensitive and validated colorimetric method was developed and optimized for the estimation of amikacin sulfate in pure and pharmaceutical dosage forms. Ascorbic acid was used as a chromogenic reagent to produce a stable color complex with amikacin that absorbs strongly at 390nm and 540nm. Several experimental factors were evaluated to maximize color development and stability, including solvent, reagent concentration, reaction time, and temperature. Optimal conditions were found using DMSO solvent, 0.2% ascorbic acid, and 40 minutes reaction time at 25°C. Under these conditions, Beer's law was obeyed in the range of 40-200μg/mL with high correlation coefficients, indicating excellent linearity. The method was validated in terms of linearity, accuracy, precision, detection/quantitation limits, and application to actual samples as per ICH guidelines. Recovery studies showed nearly 101% accuracy. Low relative standard deviations reflected high precision. Limits of detection/quantitation were 19-57μg/mL, enabling reliable analysis even at low concentrations. The method quantified amikacin content in injections, giving 98-102% accuracy. Statistical comparisons to a validated method gave no significant differences, confirming this approach provides equivalent results.
... It is known to have a selective reaction with ammonia and primary aliphatic amines of the type R-CH 2 -NH 2 (λ max 390 and 530 nm) (Pesez and Bartos, 1974). This reagent was reported to be used in the determination of various drugs including lisinopril (Rahman et al., 2005), paromomycin (Adam et al., 2016b), gabapentin (Adam et al., 2016a), and tranexamic acid (Gadkariem et al., 2013). Most of the reported methods for PGN analysis need highly trained personnel, expensive or unavailable equipment or reagents. ...
Article
Full-text available
A simple, accurate and precise colorimetric method was developed for the quantiϑication of pregabalin (PGN) in bulk and pharmaceutical formulations. The method was based on the production of a colored complex by reacting PGN with ascorbic acid in DMSO solvent. The resultant complex exhibits absorption maxima at 390 and 532 nm. The factors that affect the complex development and stability were studied and optimized. The reaction stoi- chiometry of drug: reagent was found to be 1:2. The method was then vali- dated according to ICH guidelines. Regression analysis of Beer’s plot showed good correlation (r2 value more than 0.998) within a concentration range of 5-30µg/ml. Linearity was conϑirmed by standardized residuals versus ϑit- ted value plots using Minitab14 software. The limits of detection and quan- tiϑication at 390 and 532nm were 1.34µg/ml, 1.09µg/ml and 4.05µg/ml, 3.294µg/ml, respectively. Added recovery measurements were found to be 100.04±2.07% and 99.58 ±1.98% at 390nm and 532nm, respectively, which reϑlect the accuracy of the method and freedom from interference (relative standard deviation values were less than or equal 0.2%). The average assay for the commercial capsule preparation (PGN 150mg/capsule) was found to be 101.373±0.49 and 101.812±0.73 at 390 and 532nm, respectively. The developed method is an inexpensive, extraction free and can be applied for routine analysis of PGN in most of analytical laboratories
... The absorption spectrum of the purple-pink colored complex produced by coupling of paromomycin sulphate with oxidized form of ascorbic acid (dehydroascorbic acid) gave two peaks at 390nm & at 530nm [11]. ...
  • E A Gadkariem
  • M Abounassif
  • A M Wahabi
E.A. Gadkariem, M.A Abounassif, A.M. Wahabi, Talanta, 1985, 33, 180-181.
  • F S El-Shafie
  • E A Gadkariem
  • K A Al-Rashood
  • H A Al-Khamees
F.S. El-Shafie, E.A. Gadkariem, K.A. Al-Rashood, H.A. Al-Khamees, H.A. El-Obeid, Anal Lett., 1996, 29, 3, 381–393.
  • H A El-Obeid
  • E A Gadkariem
  • K A Alrashood
  • H A Al-Khamees
  • F S El-Shafie
  • G A M Bawazeer
H.A. El-Obeid, E.A. Gadkariem, K.A. Alrashood, H.A. Al-Khamees, F.S. El-Shafie, G.A.M. Bawazeer, Anal Lett., 1999, 32, 2809-2823.
  • R Oretel
  • V Neumeister
  • W Kirch
R. Oretel, V. Neumeister, W. Kirch, J. chroma. A, 2004, 1058, 1-2, 197-201.
  • S W Shantier
  • E Gadkariem
  • K Ibrahim
S.W. Shantier, E. A GadKariem, K.E Ibrahim, Int. J. Dru. Form. Res., 2012, 2, 260-272.
  • J Pick
  • L L Oison
  • W Y Ellis
  • P Lim
J. Pick, L.L. Oison, WY. Ellis, P. Lim, J. Pharm. Biomed. Anal., 1997, 16, 1, 131-137.
Martindale: The Complete Drug Reference
  • S Sweetman
S. Sweetman, Martindale: The Complete Drug Reference, London, Pharmaceutical Press, 2002, 33 rd ed.
  • H A Elobied
  • E A Gadkariem
  • K A Al
  • H A Rashood
  • F S Al-Khamees
  • G A M El-Shafie
  • Bawazeer
H.A. ELobied, E.A.Gadkariem, K.A. AL.Rashood, H.A. Al-Khamees, F.S. El-Shafie, G.A.M. Bawazeer, Anal. Lett., 1999, 32,14, 2809-2823.
  • S W Shantier
  • E Gadkariem
  • K Ibrahim
  • M E Hagga
S.W. Shantier, E. A GadKariem, K.E Ibrahim, M.E. Hagga, Res. J. Pharm. Bio. Chem. Sci., 2012, 3, 1, 566-573.